ICAM1 and metabolic dysfunction-associated steatotic liver disease: Here we show that WD treatment also leads to increased ICAM-1 expression in liver, adipose tissue, colon, and small intestine of WT mice, pointing to an obesity-induced inflammatory status within those tissues and supporting the notion of their joint involvement in MASLD progression.